PEREGRINE CAPITAL MANAGEMENT LLC

Position in ADMA — Adma Biologics, Inc.

CIK 764529 MINNEAPOLIS, MN

Position in ADMA

as of Mar 31, 2026 · filed Apr 23, 2026 Compact

Position Value

$5,512,552

-$3,086,805 QoQ

Shares Held

611,826

+29.8% QoQ

Ownership

0.264%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 36.68118059709787.ToString("F0")% Shared 0.ToString("F0")% None 63.318819402902136.ToString("F0")%

Healthcare · as of Mar 31, 2026

PEREGRINE CAPITAL MANAGEMENT LLC holds $94,824,642 across 14 Biotechnology names. ADMA ranks #13 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	XENE	Xenon Pharmaceuticals Inc.	143,136	$8,323,358
2	BMRN	Biomarin Pharmaceutical Inc	146,923	$8,299,680
3	AXSM	Axsome Therapeutics, Inc.	47,296	$7,993,969
4	COGT	Cogent Biosciences, Inc.	201,959	$7,773,401
5	ARQT	Arcutis Biotherapeutics, Inc.	306,272	$7,215,768
6	SRRK	Scholar Rock Holding Corp	146,606	$7,207,150
7	CYTK	Cytokinetics Inc	103,626	$6,829,989
8	EWTX	Edgewise Therapeutics, Inc.	208,672	$6,573,168

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,512,552	611,826	+29.8%	Shares	Sole	2026-04-23
2025-12-31	$8,599,357	471,456	-11.1%	Shares	Sole	2026-01-28
2025-09-30	$7,777,481	530,524	+16.2%	Shares	Sole	2025-10-23
2025-06-30	$8,315,705	456,656	+13.3%	Shares	Sole	2025-08-01
2025-03-31	$7,998,317	403,141	-7.6%	Shares	Sole	2025-04-25
2024-12-31	$7,480,778	436,197	+3.7%	Shares	Sole	2025-01-31
2024-09-30	$8,411,272	420,774	-30.6%	Shares	Sole	2024-10-24
2024-06-30	$6,777,684	606,233	-25.6%	Shares	Sole	2024-07-29
2024-03-31	$5,379,290	815,044	-7.7%	Shares	Sole	2024-04-26
2023-12-31	$3,991,083	882,983	+625.8%	Shares	Sole	2024-01-26
2021-03-31	$214,116	121,657	—	Shares	Sole	2021-05-11
No filing history on record for this holder in this stock.